Transl Psychiatry:食用水产品可降低抑郁症病发率

2017-09-29 佚名 “cell”微信号

日本国立癌症研究中心和庆应私塾大学的合作团队于 9 月 27 日在美国的精神病学杂志《Transl Psychiatry》上发表论文称:他们的流行病学调查结果表明,多吃鱼、贝类等水产的人,其抑郁症发病率比一般人小了一半。同时研究还认为,青背类鱼中富含的“ω-3脂肪酸”对预防抑郁症有一定效果。

日本国立癌症研究中心和庆应私塾大学的合作团队于 9 月 27 日在美国的精神病学杂志《Transl Psychiatry》上发表论文称:他们的流行病学调查结果表明,多吃鱼、贝类等水产的人,其抑郁症发病率比一般人小了一半。同时研究还认为,青背类鱼中富含的“ω-3脂肪酸”对预防抑郁症有一定效果。

研究团队从 1990 年开始,对日本长野县南佐久郡 40-59 岁之间的 1181 位居民进行了 25 年的追踪调查,研究 19 种水产的摄入量和抑郁症之间的关系。他们按照每日摄入量的不同,从多到少将调查对象分为四组。其中第二组 (摄入量中间值为 111 克) 与最后一组 (摄入量中间值为 57 克) 相比,抑郁症发病率低了 56%。而摄入量最多的一组,虽然发病率还要再低 26%,但也是受到其他食材和烹调方式影响的结果。




ω-3脂肪酸在合成大脑内传递信息的关联物质和增加神经营养物质等方面有重要作用。通过计算脂肪酸的摄入量可以发现,同属ω-3脂肪酸的二十碳五烯酸 (EPA) 和二十二碳五烯酸 (DPA) 摄入得多,抑郁症发病率就相应地有减少倾向。癌症研究中心的健康支援研究部长 (营养精神医学) 松冈丰提到:“和吃肉的人数相比,最近几年吃水产的人数有在减少。希望这次的研究成果能成为一个契机,让大家重新看到吃鱼的好处。”

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792084, encodeId=6c831e92084c5, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 13 00:07:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067280, encodeId=abe6206e2803e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jul 09 04:07:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656885, encodeId=bf731656885b6, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun May 06 05:07:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249082, encodeId=902224908252, content=这个我喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Sep 30 10:30:12 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248916, encodeId=a10e24891636, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Sep 29 22:51:55 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792084, encodeId=6c831e92084c5, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 13 00:07:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067280, encodeId=abe6206e2803e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jul 09 04:07:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656885, encodeId=bf731656885b6, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun May 06 05:07:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249082, encodeId=902224908252, content=这个我喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Sep 30 10:30:12 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248916, encodeId=a10e24891636, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Sep 29 22:51:55 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1792084, encodeId=6c831e92084c5, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 13 00:07:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067280, encodeId=abe6206e2803e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jul 09 04:07:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656885, encodeId=bf731656885b6, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun May 06 05:07:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249082, encodeId=902224908252, content=这个我喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Sep 30 10:30:12 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248916, encodeId=a10e24891636, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Sep 29 22:51:55 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2018-05-06 bsmagic9140
  4. [GetPortalCommentsPageByObjectIdResponse(id=1792084, encodeId=6c831e92084c5, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 13 00:07:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067280, encodeId=abe6206e2803e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jul 09 04:07:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656885, encodeId=bf731656885b6, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun May 06 05:07:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249082, encodeId=902224908252, content=这个我喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Sep 30 10:30:12 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248916, encodeId=a10e24891636, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Sep 29 22:51:55 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-30 sunfeifeiyang

    这个我喜欢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1792084, encodeId=6c831e92084c5, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 13 00:07:00 CST 2017, time=2017-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067280, encodeId=abe6206e2803e, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Jul 09 04:07:00 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1656885, encodeId=bf731656885b6, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Sun May 06 05:07:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=249082, encodeId=902224908252, content=这个我喜欢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Sat Sep 30 10:30:12 CST 2017, time=2017-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248916, encodeId=a10e24891636, content=好资料学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Sep 29 22:51:55 CST 2017, time=2017-09-29, status=1, ipAttribution=)]
    2017-09-29 thlabcde

    好资料学习了!

    0

相关资讯

Biol Psychiat:抑郁症患者易自杀 大脑炎症难逃责任

抑郁症不仅仅是一种心理疾病,它背后同样存在复杂的生理基础。近日,一项来自曼彻斯特大学的研究发现,抑郁症患者的自杀念头与大脑炎症之间存在关联。这是科学家首次在活体中证实这种联系。该研究发表于Biological Psychiatry期刊上。

eLife:黑科技助力神经疾病治疗

来自布法罗大学的研究人员开发了一种名为磁热刺激的技术,通过利用磁性纳米粒子刺激装备了温度敏感性离子通道的神经元,从而激活特定一组神经元。研究人员借此可以控制小鼠的身体运动,包括跑步、旋转和失去运动能力。

大胆!可致幻的魔术蘑菇用于治疗抑郁症?

魔术蘑菇(Magic Mushrooms)参加临床试验 英国初创公司测试迷幻药物治疗抑郁症的有效性

KK健康:你是抑郁症,还是忧郁情绪?来对号入座吧!

抑郁症是以显著、持续、普遍的抑郁状态为表现形式的一种精神疾病。目前抑郁症是全球第四大疾病负担,也是导致患者功能残疾的主要原因之一,大约有1/7的人会在人生的某个阶段遭受抑郁症困扰。

2017 佛罗里达更佳实践指南:成人抑郁症的药物治疗

2017年,佛罗里达专家工作组(Florida Expert Panel)对2015年版的佛罗里达精神科药物治疗最佳实践指南(FPG)——成人抑郁症部分进行了修订。 指南对规范化诊疗、基于量化的治疗、全面评估及总体躯体/精神健康的管理进行了强调。证据重视抑郁标注(Specifiers,如混合特征、焦虑痛苦等)及药物遗传学(及其他生物行为标记物)在指导治疗决策选择中的意义。

Biol Psychiat:科学家发现,“神经炎症”是导致抑郁症患者自杀的主要因素

英国曼彻斯特大学(University of Manchester)的一项新研究表明,患有重度抑郁症(MDD)的患者大脑中出现了一种神经胶质激活的标志,这是一种炎症。在这项研究中,彼得·塔尔博特博士和他的同事们发现,炎症标志物的增加,只会在患有MDD的身上出现,因为他们有自杀的想法。将炎症的作用确定在自杀倾向上,而不是诊断MDD本身。